GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Chemomab Therapeutics Ltd. (CMMB) | 10/30/2026 4:34:42 PM | View | Proxy | SEC | Y 2025 | ||||||
| Chemomab Therapeutics Ltd. (CMMB) | 8/19/2026 8:28:10 AM | View | Financials | Earnings | WIRE | 2Q 2026 | Export Earnings Model | ||||
| Chemomab Therapeutics Ltd. (CMMB) | 5/14/2026 8:01:00 AM | View | Financials | Earnings | WIRE | 1Q 2026 | Export Earnings Model | ||||
| Chemomab Therapeutics Ltd. (CMMB) | 3/23/2026 4:15:12 PM | Micro | View | Financials | 20-F | SEC | Y 2025 ending: 12/31/2025 | Assets $13,812,000 | EPS $0.02 | ||
| Chemomab Therapeutics Ltd. (CMMB) | 3/19/2026 8:01:17 AM | View | Financials | Earnings | WIRE | Y 2025 | Assets $13,812,000 | Export Earnings Model | |||
| Chemomab Therapeutics Ltd. (CMMB) | 11/20/2025 8:02:18 AM | View | Financials | Earnings | WIRE | 3Q 2025 | Export Earnings Model | ||||
| Chemomab Therapeutics Ltd. (CMMB) | 8/14/2025 8:02:19 AM | View | Financials | Earnings | WIRE | 2Q 2025 | Export Earnings Model | ||||
| Chemomab Therapeutics Ltd. (CMMB) | 5/15/2025 8:02:48 AM | View | Financials | Earnings | WIRE | 1Q 2025 | Export Earnings Model | ||||
| Chemomab Therapeutics Ltd. (CMMB) | 4/4/2025 5:22:12 PM | Micro | View | Financials | 20-F | SEC | Y 2024 ending: 12/31/2024 | Assets $16,964,000 | EPS $0.04 | ||
| Chemomab Therapeutics Ltd. (CMMB) | 8/21/2024 7:02:04 AM | View | Financials | Earnings | WIRE | 2Q 2024 | Assets $14,544,000 | EPS $0.01 | Export Earnings Model | ||
| Chemomab Therapeutics Ltd. (CMMB) | 5/9/2024 7:01:53 AM | View | Financials | Earnings | WIRE | 1Q 2024 | Export Earnings Model | ||||
| Chemomab Therapeutics Ltd. (CMMB) | 3/28/2024 6:26:09 AM | Micro | View | Financials | 20-F | SEC | Y 2023 ending: 12/31/2023 | Assets $22,151,000 | EPS $0.10 | ||
| Chemomab Therapeutics Ltd. (CMMB) | 3/7/2024 7:01:20 AM | View | Financials | Earnings | WIRE | Y 2023 | Assets $22,151,000 | Export Earnings Model | |||
| Chemomab Therapeutics Ltd. (CMMB) | 11/9/2023 8:01:50 AM | View | Financials | Earnings | WIRE | 3Q 2023 | Export Earnings Model | ||||
| Chemomab Therapeutics Ltd. (CMMB) | 8/14/2023 8:01:09 AM | View | Financials | Earnings | WIRE | 2Q 2023 | Assets $28,849,000 | EPS $0.04 | Export Earnings Model | ||
| Chemomab Therapeutics Ltd. (CMMB) | 5/11/2023 6:24:23 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $35,013,000 | EPS $0.04 | ||
| Chemomab Therapeutics Ltd. (CMMB) | 5/11/2023 6:11:04 AM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $35,013,000 | EPS $0.04 | Export Earnings Model | ||
| Chemomab Therapeutics Ltd. (CMMB) | 3/20/2023 6:19:12 AM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Assets $43,063,000 | EPS $0.12 | ||
| Chemomab Therapeutics Ltd. (CMMB) | 2/21/2023 6:13:06 AM | View | Financials | Earnings | SEC | Y 2022 | Assets $43,063,000 | EPS $0.04 | Export Earnings Model | ||
| Chemomab Therapeutics Ltd. (CMMB) | 11/11/2022 6:05:29 AM | View | Financials | Earnings | WIRE | 3Q 2022 | Assets $50,219,000 | EPS $0.04 | Export Earnings Model | ||
| Chemomab Therapeutics Ltd. (CMMB) | 11/10/2022 4:27:40 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Assets $50,219,000 | EPS $0.04 | ||
| Chemomab Therapeutics Ltd. (CMMB) | 8/12/2022 7:48:58 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $56,378,000 | EPS $0.03 | ||
| Chemomab Therapeutics Ltd. (CMMB) | 8/12/2022 7:09:01 AM | View | Financials | Earnings | SEC | 2Q 2022 | Assets $56,378,000 | EPS $0.03 | Export Earnings Model | ||
| Chemomab Therapeutics Ltd. (CMMB) | 5/12/2022 8:31:28 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $60,956,000 | EPS $0.02 | ||
| Chemomab Therapeutics Ltd. (CMMB) | 5/12/2022 6:22:05 AM | View | Financials | Earnings | SEC | 1Q 2022 | Assets $60,956,000 | EPS $0.02 | Export Earnings Model | ||
| Chemomab Therapeutics Ltd. (CMMB) | 4/28/2022 4:21:23 PM | View | Proxy | SEC | Y 2021 | ||||||
| Chemomab Therapeutics Ltd. (CMMB) | 3/30/2022 4:57:20 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Assets $64,353,000 | EPS $0.06 | ||
| Chemomab Therapeutics Ltd. (CMMB) | 3/9/2022 6:08:27 AM | View | Financials | Earnings | SEC | Y 2021 | Assets $64,353,000 | EPS $0.02 | Export Earnings Model | ||
| Chemomab Therapeutics Ltd. (CMMB) | 1/5/2022 4:04:26 PM | View | Proxy | SEC | Y 2021 | ||||||
| Chemomab Therapeutics Ltd. (CMMB) | 11/12/2021 8:41:18 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $67,440,000 | EPS $0.01 | ||
| Chemomab Therapeutics Ltd. (CMMB) | 11/12/2021 7:46:22 AM | View | Financials | Earnings | SEC | 3Q 2021 | Assets $67,440,000 | EPS $0.01 | Export Earnings Model | ||
| Chemomab Therapeutics Ltd. (CMMB) | 9/17/2021 4:08:00 PM | View | Proxy | SEC | Y 2020 | ||||||
| Chemomab Therapeutics Ltd. (CMMB) | 8/13/2021 8:13:19 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Assets $70,518,000 | EPS $0.01 | ||
| Chemomab Therapeutics Ltd. (CMMB) | 8/13/2021 8:04:36 AM | View | Financials | Earnings | SEC | 2Q 2021 | Assets $70,518,000 | EPS $0.01 | Export Earnings Model | ||
| Chemomab Therapeutics Ltd. (CMMB) | 6/14/2021 4:05:31 PM | View | Proxy | SEC | Y 2020 | ||||||
| Chemomab Therapeutics Ltd. (CMMB) | 5/13/2021 9:31:55 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Assets $60,123,000 | EPS $0.01 | ||
| Chemomab Therapeutics Ltd. (CMMB) | 5/13/2021 9:30:59 AM | View | Financials | Earnings | SEC | 1Q 2021 | Assets $60,123,000 | EPS $0.01 | Export Earnings Model | ||
| Anchiano Therapeutics Ltd. (CMMB) | 3/9/2021 4:33:48 PM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Assets $12,476,000 | EPS $0.04 | ||
| Anchiano Therapeutics Ltd. (CMMB) | 11/16/2020 10:16:36 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Assets $7,689,000 | EPS $0.01 | ||
| Anchiano Therapeutics Ltd. (CMMB) | 8/14/2020 10:19:16 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Assets $10,016,000 | EPS $0.01 | ||
| Anchiano Therapeutics Ltd. (CMMB) | 5/11/2020 4:03:04 PM | View | Financials | Earnings | WIRE | 1Q 2020 | Assets $15,183,000 | EPS $0.01 | Export Earnings Model | ||
| Anchiano Therapeutics Ltd. (CMMB) | 5/7/2020 4:47:22 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Assets $15,183,000 | EPS $0.01 | ||
| Anchiano Therapeutics Ltd. (CMMB) | 4/6/2020 6:12:19 AM | View | Proxy | SEC | Y 2019 | ||||||
| Anchiano Therapeutics Ltd. (CMMB) | 3/18/2020 12:36:39 PM | View | Financials | Earnings | WIRE | Y 2019 | Assets $19,755,000 | EPS $1.43 | Export Earnings Model | ||
| Anchiano Therapeutics Ltd. (CMMB) | 3/17/2020 5:33:07 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Assets $19,755,000 | EPS $0.79 | ||
| Anchiano Therapeutics Ltd. (CMMB) | 11/15/2019 8:31:14 AM | View | Financials | Earnings | WIRE | 2Q 2020 | Assets $10,016,000 | EPS $0.01 | Export Earnings Model | ||
| Anchiano Therapeutics Ltd. (CMMB) | 8/5/2019 5:16:42 PM | View | Financials | Earnings | WIRE | 3Q 2020 | Assets $7,689,000 | EPS $0.01 | Export Earnings Model | ||
| Anchiano Therapeutics Ltd. (CMMB) | 4/24/2019 5:33:12 PM | Micro | View | Financials | 20-F/A | SEC | Y 2018 ending: 12/31/2018 | Assets $12,761,000 |